This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by GE Healthcare US.
NNT = Number needed to treat
Reference
O'Day K, et al. Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA. Applied Health Economics and Health Policy : 14 Mar 2016. Available from: URL: http://dx.doi.org/10.1007/s40258-016-0234-5
Rights and permissions
About this article
Cite this article
Screening ICD-eligible HF patients reduces ICD costs. PharmacoEcon Outcomes News 749, 29 (2016). https://doi.org/10.1007/s40274-016-2916-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2916-5